RBR-4pfygr尚未招募1 期
Clinical study to evaluate the safety and tolerability of intravenous infusion of plasma from human umbilical cord and placental blood (Plasmacord®) in patients with Severe Acute Respiratory Syndrome resulting from Sars-Cov-2 infection
CRYOPRAXIS - CRIOBIOLOGIA LTDA0 个研究点开始时间: 2020年8月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
入选标准
- •Age over 18 years; both sexes; positive test for COVID-19; indication for transfer to the intensive care unit (ICU) by the responsible medical team; according to institutional criteria and protocols; absence of therapeutic alternative
排除标准
- •Pregnant women; under 18 years old; no indication of transfer to the intensive care unit (ICU) by the responsible medical team; according to institutional criteria and protocols; existence of therapeutic alternative
研究者
相似试验
进行中（未招募）
不适用
Study to evaluate the safety of human immune globulin in patients withprimary immunodeficiency diseases.EUCTR2011-005015-82-Outside-EU/EEAOctapharma AG20
已完成
3 期
Clinical study to evaluate the safety and tolerability of immunoglobulin intravenous (human) 10% (NewGam) administered at high infusion rates to patients with primary immunodeficiency diseasesISRCTN11002924Octapharma AG (Switzerland)35
尚未招募
1 期
A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adultsovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003169anjing University
招募中
不适用
safety and effectiveness of Soreze gel in pressure ulcerCTRI/2021/06/034297Amaterasu Lifesciences
未知
2 期
A study to evaluate ABT-450 with Ritonavir (ABT-450/r) and ABT-267 in Japanese adults with chronic Hepatitis C Virus infectioJPRN-jRCT2080221883AbbVie GK96